الفهرس 
AcknowledmentOnly 14 pages are availabe for public view
 |  | from | 85 |  |  |
| | | from | 85 | | |
Abstract
DWA was superior to co-VMAT regarding dose distributions in the duodenum in LAPC, albeit with slight increasing doses to the liver and the spinal cord and increasing MU and beam delivery time. Further evaluation is needed to know how the dose differences would affect clinical outcomes in chemoradiotherapy for LAPC. These findings would help further the clinical studies of IMRT for LAPC, with escalating doses to the tumor while keeping less duodenal toxicities.